ARCHIVES

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 35 No. 26 | July 3, 2009

Download PDF Visit The Full Archive

Related Articles

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

NIH And E.I. Dupont Sign OncoMouse Agreement.

January 28, 2000

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

U.S., France Offer Carcinogenesis Program

February 13, 1981

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982